CIK 0001398733
- Non-accelerated filer
- Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208623253
- Phone
- +1 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,714 shares (to pay taxes)
- 4 Grant or award Chief Legal Officer acquired 100,000 shares (grant or award)
- 4 Planned sale President and CEO sold 8,257 shares at $4.29 ($35,413)
- 4 Shares withheld for taxes SVP, Regulatory Affairs gave up 1,667 shares (to pay taxes)
- 4 Shares withheld for taxes Corporate Secretary gave up 135,690 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People Officer gave up 56,778 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 335,922 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 92,652 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 72,734 shares (to pay taxes)
- 4 Shares withheld for taxes Corporate Secretary gave up 76,147 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief People Officer sold 29,814 shares at $4.17 ($124,414)
Page 2 of 17 · 325 filings